Skip to main content

Checkpoint Therapeutics, Inc.

CKPTDelisted May 30, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001651407

Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in Checkpoint Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

CKPT is no longer listed, so this page shows Q1 2025. 13F filings for later quarters list far fewer holders.

Institutional holders
84
+16 vs. Q4 2024
Shares held
34.1M
+23.0M (+207.7%) vs. Q4 2024
Total value
$137.7M
+$102.2M (+288.2%) vs. Q4 2024
New holders
39
19 more added
Sold out
23
15 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CKPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 84 institutions
Q1 2021: 71 institutionsQ2 2021: 70 institutionsQ3 2021: 68 institutionsQ4 2021: 62 institutionsQ1 2022: 67 institutionsQ2 2022: 62 institutionsQ3 2022: 57 institutionsQ4 2022: 40 institutionsQ1 2023: 34 institutionsQ2 2023: 35 institutionsQ3 2023: 39 institutionsQ4 2023: 43 institutionsQ1 2024: 39 institutionsQ2 2024: 45 institutionsQ3 2024: 47 institutionsQ4 2024: 68 institutionsQ1 2025: 84 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $137.7M
Q1 2021: $50.9MQ2 2021: $32.5MQ3 2021: $34.9MQ4 2021: $33.4MQ1 2022: $22.8MQ2 2022: $10.3MQ3 2022: $11.7MQ4 2022: $9.12MQ1 2023: $3.76MQ2 2023: $6.51MQ3 2023: $6.68MQ4 2023: $11.2MQ1 2024: $11.0MQ2 2024: $12.6MQ3 2024: $17.2MQ4 2024: $35.5MQ1 2025: $137.7MQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CKPT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 202584$137.7M
Q4 202468$35.5M
Q3 202447$17.2M
Q2 202445$12.6M
Q1 202439$11.0M
Q4 202343$11.2M
Q3 202339$6.68M
Q2 202335$6.51M
Q1 202334$3.76M
Q4 202240$9.12M
Q3 202257$11.7M
Q2 202262$10.3M
Q1 202267$22.8M
Q4 202162$33.4M
Q3 202168$34.9M
Q2 202170$32.5M
Q1 202171$50.9M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Checkpoint Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding CKPT in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Boothbay Fund Management, LLC0$00.00%−10,888−100.0%Sold out
Rothschild Investment LLC0$00.00%−10,000−100.0%Sold out
HighTower Advisors, LLC0$00.00%−8,500−100.0%Sold out
FMR LLC0$00.00%−3,613−100.0%Sold out
Medallion Wealth Advisors, LLC0$00.00%−3,500−100.0%Sold out
Citadel Advisors LLC0$00.00%−263−100.0%Sold out
US Bancorp0$00.00%−22−100.0%Sold out